CD80 and neoplasm: The secretion of exosomal peptide MHC I is transferred to CD8+ T cells under the influence of released IL-2 and exosomal CD80, leading to increased proliferation of CD8+ T cells and the production of a more robust anti-tumor immune response in vivo [128].